010101100110100111100110111100000101010011000101100010111000001100011010011110011011110000010101001100010110001011100001001000010001000010000101111010101010111100000001011100010111001100011010011110011011110000010101001100010110001011100001001000010001000010011010011110011010011110011011110000010101001100010110001011100001001000
AT THE FOREFRONT OF TRANSPLANT CARE
Kidney
Combined Kidney-Pancreas
Pancreas
Islets
Where World-Class Expertiseand Genuine Compassion
Come Together
transplants since the procedures were introduced—more than any
other hospital in Illinois. And, year after year, our success rates
consistently outpace national averages.
At the University of Chicago Hospitals, the bar for medical
miracles continues to rise: Patients who have challenging illnesses
or medical conditions are walking out our doors with newly
transplanted organs … Islet transplants are quickly becoming
a viable alternative for many who suffer from type 1 diabetes …
More and more living and deceased donor organs are becoming
available thanks to innovative new approaches … And medicines
and other treatments developed here and elsewhere are helping
to ensure that patients can keep transplanted organs for many,
many years—with fewer side effects.
Where the Best Is Available…
Over the last half century, the University of Chicago Hospitals’
name has become synonymous with excellence—and with
reason. No other hospital in Illinois has been consistently
named one of the top hospitals in the United States by
U.S. News and World Report.
Our formula for success is simple: Bring together the best
and the brightest clinicians, and give them the support they
need to discover new treatment approaches and deliver
state-of-the-art care.
Consider the knowledge and experience of our transplant team:
Together, our physicians and nurses have more than 250 years
experience in kidney and pancreas care. Our surgeons have
conducted thousands of transplant surgeries, earning national
and international esteem for their surgical expertise and
research. They work side-by-side with specially trained
transplant nephrologists, endocrinologists, and nurses who
provide unmatched expertise before and after a transplant.
21
Turning Hope into Reality
Think of it: No more dialysis, if you
suffer from kidney failure. No more
insulin shots, if you have diabetes.
Imagine the sheer joy of eating foods
you may not have been able to enjoy
for a long time. Picture a more active
life off of dialysis—one that allows you
to work and travel. Consider all the
things that you could do with your
time if you could get back the energy
that was robbed from you by kidney
disease or other health problems.
Not so long ago, transplantation
was considered a miracle of modern
medicine. Today, the transplant team
at the University of Chicago Hospitals
performs these miracles on a routine
basis. In fact, we have performed
thousands of kidney and pancreas
“Everybody at U of C is
so accessible. I can call
them at any t ime,
at night, or on the
weekends. This was so
important after my
first transplant when
I felt so overwhelmed.
That first weekend
I was home, I just
needed to check in,
and they were right
there for me. They
really take care of you
as a whole person,
not just your organs.”
Debbie, a 42-year-oldtransplant patient
10110011010011110011011110000010101001100010110001011100001001000010001000010000101111010101010111100001010010000101110000110100111100110111100000101010011000101100010111000010010000100010000100001011110101010101111000010100100001011100010 1110011000110100111100110111100000101010011000101100010111000010010000100010000100100111100110100111100110111100000101010011000101100010111000010010000100010000100001011110101010101111000010100100001011100010000100001000010111
Our team also includes a transplant
pharmacist, social worker, financial
counselor, and other support staff who
work solely with transplant patients.
One of our patients put it best: “It takes
a lot of pressure off when you have
confidence in your doctors and in the
hospital.” When you come to the
University of Chicago Hospitals for
transplant care, you can be certain
that you are in expert hands. Another
reassuring fact: If you or a loved one
develops other medical problems, you
will have access to hundreds of other
knowledgeable experts. The University
of Chicago Hospitals is home to some of
the world’s most respected specialists in
diabetes, kidney disease, cancer, heart
disease, digestive problems, and other
health problems.
“What really impressed
me was the speed
with which all of this
happened. I thought I
would run into a lot
of bureaucracy with
insurance issues and all.
But the pre-transplant
coordinator handled all
of that and pushed
everything through
very quickly. And the
aftercare was just as
thorough. The nurses
were cal l ing me at
home all the time to see
how I was doing. They
take such an interest in
you that it motivates
you to take an interest
in your health, too.”
Mark, a 38-year-oldliving donor kidneyrecipient
010101100110100111100110111100000101010011000101100010111000010010000100010000100001011110101010101111000010100100001011011000110100111100110111100000101010011000101100010111000010010000100010000100001011110101010101111000010100100001011100010 11100110001101001111001101111000001010100110001011000101110000100100001000100001011010011110011010011110011011110000010101001100010110001011100001001000010001000010000101111010101010111100001010010000101110001000010000100001
Where the Most Advanced Treatments Can Be Found
The University of Chicago Hospitals is an academic medical
center, which means that many of our physicians conduct
research as well as provide care. This approach provides
patients with a major advantage: You get access to new
therapies and medicines before they’re commonly available
elsewhere. If something is discovered in kidney and/or
pancreas transplant care, chances are our physicians and
researchers were involved in the discovery or are on top of
what is going on.
For instance, our physicians have been investigating why
transplant patients are at risk of losing organs from a common
virus, called the polyoma virus. They are at the forefront of
developing new methods for treating the virus, hopefully
keeping more patients’ transplants healthier.
Our physicians and researchers are also considered leaders
in immunosuppression—or the prevention and treatment of
organ rejection. They have helped develop and refine many
43
Making Transplant a Viable Option for More People
Because of the level of expertise available at the University of
Chicago Hospitals, our expert surgeons and physicians commonly
take on patients who may be considered too sick or old for
transplantation—saving or enhancing many lives each year. For
instance in 1988, we were the first hospital in Illinois to perform
a pancreas transplant on a patient with advanced diabetes.
More recently, we have been performing an increasing number
of re-transplants on patients who received organs in the past.
Re-transplant patients require more careful management than
first-time transplants because the body is more likely to reject an
organ after a second or third transplant. Before surgery, we may
provide re-transplant patients—or “sensitized” individuals—
with specialized immunosuppressive treatment to help ensure
a successful re-transplant.
Our surgeons and physicians are also considered some of the
most experienced in the world when it comes to multiple-organ
transplants. The first successful heart-liver-kidney transplant in the
world was performed at the University of Chicago Hospitals. We
also performed the first heart-kidney-pancreas transplant in Illinois.
important anti-rejection medications,
including OKT3, which was a mainstay
immunosuppression drug for more than
a decade. Thankfully, the science of
immunosuppression has become so
accurate that organ rejection is now
a less common occurrence in patients
who take their medications as directed.
With that challenge met, our physicians
and researchers are focusing on the
next challenge: preventing and
treating other common problems
that develop in transplant patients,
such as high blood pressure, scarring
that develops in transplanted organs,
and viral infections.
“Everybody I met at thehospital conveyed trueconcern and caring.I was really amazedthat so many doctorscame to talk to me,to sit down with meand ask ‘What did Ithink of this’ and say ‘Here are the possible pros and cons of this’.Everybody there reallytook care of me as one human being to anotherhuman being. Theytruly demonstrated tome what compassiona n d c o n c e r n a r e all about.”
Sam, 49-year-old kidney-pancreasrecipient
010101100110100111100110111100000101010011000101100010111000010010000100010000100001011110101010101111000010100100001011011000110100111100110111100000101010011000101100010111000010010000100010000100001011110101010101111000010100100001011100010 1110011000110100111100110111100000101010011000101100010111000010010000100010000111010011110011010011110011011110000010101001100010110001011100001001000010001000010000101111010101010111100001010010000101110001000010000100001
65
Experience and Compassion Go Hand in Hand
We realize that, from the outside, the University of ChicagoHospitals can seem rather big and imposing. But once you stepinside and get to know our transplant team, we’re certain thatyou’ll see what a small place this really is. We may do a largenumber of transplants, but we become very close to each andevery one of our patients. In fact, we like to think of ourselves as an extended family. We go out of our way to provide you with compassionate care.
To us, compassionate care is about the big things and the littlethings. It means getting laboratory tests back in a timely mannerso we can quickly identify and treat any problems. But it’s alsoasking you about your family and how they’re handling lifebefore or after transplant. It’s about giving you the education you need to understand all the in’s and out’s of caring for yourself after a transplant. And it’s also about being available 24 hours a day to calm any worries or answer any questions.
After taking into account all the medical miracles and advancesthat have occurred at the University of Chicago Hospitals, we areproudest of something much closer to our hearts: that our patientsfeel that we care about them as people, and that we look aftertheir overall health and well being—not just their organs.
010101100110100111100110111100000101010011000101100010111000010010000100010000100001011110101010101111000010100100001011
Increasing the Number of Organs Available
In the United States there are simply not enough organs available for transplant. To help correct this deficiency, wehave made major efforts on several fronts to increase the number of organs available. We are helping more patients find appropriate living donors. Improvements in anti-rejectiontherapies now allow kidney transplants to occur between unrelated individuals. Donor kidney surgery is now almostalways performed using a minimally invasive procedure, which requires much smaller incisions than traditional surgery. As a result, living donors are recovering much more quickly and are returning to work and other activitiessoon after surgery.
We are also working diligently to increase the number of organs from deceased donors that are available for transplant.For instance, we regularly use a special perfusion pump to rehabilitate deceased donor kidneys that may not have been usable in the past.
11010011110011010011110011011110000010101001100010110001011100001001000010001000010000101111010101010111100001010010000101110001000010000100001011000110100111100110111100000101010011000101100010111000010010000100010000100001011110101010101111000010100100001011100010 111001100011010011110011011110000010101001100010110001011100001001000010001000010
“ T h e n u r s e s a n d
d o c t o r s w e r e a l l
very good. They go
out of their way to
help you, doing little
favors for you they
don’t have to do.”
Carmen, a 68-year-old kidney recipient
87
How to Contact Us
To learn more about kidney and/or pancreas transplants
at the University of Chicago Hospitals, call (773) 702-9287.
For information on islet transplants, call (773) 702-2504.
You can also visit our Web site at www.uchospitals.edu.
The University of Chicago Hospital also performs liver, heart,
intestinal, and bone marrow transplants. For information on
these other transplant programs, call 1-888-UCH-0200.
We Start by Sitting Down with You
The possibility of a transplant provides hope—hope for a better and healthier future. But the whole process can seemoverwhelming, frightening, and confusing. That’s why we take itone step at a time. The first step: We talk with you, one-on-one,to determine which specific surgical methods and medical treatments are best for you. These options may include:
Kidney-only transplants for people with kidney failure.The surgery typically eliminates the need for dialysis, andpatients report increased energy and other positive healthchanges. We perform both living and deceased donor kidneytransplants. Organs from living donors typically last longerthan organs from deceased donors. In addition, living organrecipients do not have to wait months or years for their surgery, as deceased organ recipients often do.
Pancreas-only transplants for people with type 1 diabetes whohave healthy kidney function. Many patients who receive apancreas from a deceased donor no longer need insulin shots.Their risk for kidney disease and other diabetes complicationsmay also be lower after a transplant.
Combined kidney-pancreas transplants for patients who have type 1 diabetes and significant kidney disease. Duringthe same operation, patients receive a kidney and pancreasfrom the same deceased donor. For many diabetics with kidney failure, this procedure provides the greatest hope for a life without dialysis or insulin injections.
Islet transplant for patients with type 1 diabetes. We are among a select number of hospitals in the country initiating a clinical trial of islet transplantation. During thisnon-surgical procedure, islet cells from a donated pancreas areinjected into a patient’s vein. The cells lodge within the liver and begin making insulin, regulating the patient’s blood sugar.
1010110011010011110011011110000010101001100010110001011100000011010011110011011110000010101001100010110001011100001001000010001000010000101111010101010111100001001011100010 1110011000110100111100110111100000101010011000101100010111000010010000100010000100010011110011010011110011011110000010101001100010110001011100001001000010
The University of Chicago Hospitals
Kidney and Pancreas Transplantation Services
5841 South Maryland Avenue
Chicago, Illinois 60637-1470
(773) 702-9287
www.uchospitals.edu
Islet Transplantation at the University ofChicago Hospitals
At the Forefront of Diabetes Research
The University of Chicago Hospitals has been a leader in diabetes research since the early 1900s. In fact, one of ourresearchers played a crucial role in the discovery of insulin—an event that has saved countless lives of people with type 1diabetes. Now, our researchers are helping to test anotherexciting—but experimental—treatment for type 1 diabetes:islet transplantation.
What Is Islet Transplantation?
Islets are the groups of cells in the pancreas that makeinsulin, a hormone that helps the body use blood sugar (or glucose) for energy. When a person has type 1 diabetes,their body destroys the islet cells that make insulin. Theirbodies cannot produce any insulin.So, they need to take daily insulininjections for life.
Who Is Eligible for an Islet Transplant?
People with type 1 diabetes who are between the ages of 18 and 58 are eligible. In addition, patients may also:
• Have serious complications from diabetes, such as eye,nerve, or blood vessel problems.
• Experience symptoms of low blood sugar, such as dizziness, sweating, or hunger—often without knowingthey have low blood sugar.
• Have brittle or unstable diabetes.
• Have diabetes that is very hard to control.
People who are interested in islet transplants at theUniversity of Chicago Hospitals will meet with a transplantcoordinator and transplant surgeon to review all of the risksand benefits of islet transplantation. After this meeting, thosewho are interested will be asked to sign an informed consentform. This form describes the procedure in detail and outlinesthe possible risks.
In summary, islet transplantation is an experimental procedure that may provide excellent blood sugar control for people with type 1 diabetes—without insulin or the need for surgery.
How Do I Find Out More?
For more information about islet transplants, call our Clinical Islet Transplant Coordinator at 773-702-2504.
01101111000001010100110001011000101110000100100001000100001000010111101010101011110000101001000010111000100001000010000101111000100001001001100010110001011100001001000010001000010000101111010101010111100001010010000101110001011100110001101001111001101111000001010100110001011000101110000100100001000100001111001100011010011110011011010111100001010010000101110001011100110001101001111001101111000001010100110001011000101110000100100001000100001001101111000001010100110001011000101110000100100001000100001000010111101010101011110000101001000010111000100000101
Islet transplants are intended to treat type 1 diabetes by replacing destroyed islets with new ones. No surgery is needed. The islets cells from a deceased donor’s pancreas areremoved and injected into a major blood vessel of the patient’sliver. The islet cells then begin making insulin. The transplantpatient must take special medicines, called anti-rejection medicines, to prevent his/her immune system from attacking the new islet cells.
However, islet transplants are still experimental. We still don’tknow what the long-term benefits and risks are. This is whythe University of Chicago Hospitals is conducting a clinicaltrial on islet transplantation. We plan to give 10 patients islettransplants and follow them for five years to see how wellthey do. We hope our findings will provide information on the procedure’s safety and success. Similar studies are beingconducted around the world.
Islet transplants performed at a Canadian research hospitalover the last several years show promising results. In onegroup of 12 patients who received islet transplants, nine no longer needed daily insulin injections 10 months later.
When Should Patients Consider Transplantation?
Many people with type 1 diabetes successfully control their disease with daily insulin injections. In these cases,transplantation is not needed.
But, over time, type 1 diabetes can lead to serious problems,including kidney failure, heart disease, blindness, and nervedamage. Some people also have a harder time controllingtheir diabetes than others. They have trouble keeping their blood sugar levels at normal levels, which is key to preventing serious problems. Taking insulin can also causefrequent episodes of hypoglycemia, or low blood sugar.
When type 1 diabetes cannot be controlled or is causing serious problems, a patient may want to think about transplantation. There are two possibilities: whole pancreas or islet transplantation.
Islet Versus Whole Pancreas Transplantation
Both whole pancreas and islet transplants offer the hope ofexcellent blood sugar control—without insulin injections. Butthere are advantages and disadvantages to each procedure.Below is a comparison. Transplant physicians and surgeons at the University of Chicago Hospitals can help patientsdetermine what type of transplant, if any, is best for them.
Whole Pancreas Transplant
It’s considered standard therapy. Thousands of these procedures have been performed around the world—and hundreds at the University of Chicago Hospital.
85-90% of patients transplanted with a whole pancreas have normal blood sugar without insulin one year after transplant.
Surgery is necessary. Patients stay in the hospital for about seven days.
It only requires one surgery.
It requires taking anti-rejection medicines for the life of the transplant.
see back for more islet information
Islet Transplant
It’s still experimental.
33-80% of patients transplantedwith isolated islets have normalblood sugar without insulin oneyear after transplant.
No surgery is needed. Patientsonly stay in the hospital one day.
It may require more than one procedure.
It requires taking anti-rejectionmedicines for the life of the transplant.